Lisa A. Lacasse: US Pharmacopeia, ACS CAN and Drug Shortage Task Force address the ongoing drug shortage crisis

Lisa A. Lacasse, President at American Cancer Society Cancer Action Network, shared a post by US Pharmacopeia, on LinkedIn:

“Thanks to US Pharmacopeia for this recap of the Hill briefing they led in partnership with American Cancer Society Cancer Action Network (ACS CAN) and the Drug Shortage Task Force members to call for immediate, comprehensive solutions to address the ongoing drug shortage crisis.”

Quoting  US Pharmacopeia‘s post:

“‘Without change, I don’t know what I’ll do. We need action now.’
Deb Majcher Constien, Patient Representative | International Foundation for Autoimmune and Autoinflammatory Arthritis (AiArthritis)

US Pharmacopeia, American Cancer Society Cancer Action Network (ACS CAN), and our Drug Shortage Task Force members convened a briefing on Capitol Hill to call for immediate, comprehensive action to address the ongoing drug shortage crisis.

Learn how this crisis affects patients, providers, and health systems across the country. And…  coming soon! Be on the lookout for our inaugural Annual Drug Shortages Report, featuring data and insights from the USP Medicine Supply Map, which will shed more light on the drugs that were in shortage last year.”

Source: Lisa A. Lacasse/LinkedIn and  US Pharmacopeia/LinkedIn

Lisa Lacasse, President of the American Cancer Society Cancer Action Network (ACS CAN), has an impactful leadership in healthcare advocacy. Leading ACS CAN’s nationwide public policy advocacy agenda with her oversight of a dedicated team in Washington, D.C., she ensures effective advocacy efforts at the highest levels.

Beyond her role at ACS CAN, Lacasse’s commitment to public health extends to serving on the board for the Campaign for Tobacco-Free Kids. Her approach and dedication continue to drive positive change in the fight against cancer and tobacco-related diseases.